Ticker Details
Aprea Therapeutics, Inc.
IPO Date:	September 30, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.32M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.72%
Avg Daily Range (30 D):	$0.04 | 5.39%
Avg Daily Range (90 D):	$0.04 | 3.96%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	4.1M
Avg Daily Volume (90 D):	1.46M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	451
Avg Trade Size (Sh.) (90 D):	444

Institutional Trades
Total Institutional Trades:	121
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$.52M
Avg Institutional Trade (90 D):	$.52M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	7.56K

News

Jun 25, 2025 @ 1:00 PM Aprea Reports Anti-Proliferative Results and Promi... Source: N/A

May 14, 2025 @ 12:00 PM Aprea Therapeutics Reports First Quarter 2025 Fina... Source: N/A

Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics

Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics

May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.12	$-.47	$-.53
Diluted EPS	$-2.22	$-.47	$-.53
Revenue	$.49M	$M	$.12M
Gross Profit
Net Income / Loss	$-13.04M	$-2.97M	$-3.24M
Operating Income / Loss	$-13.82M	$-3.12M	$-3.39M
Cost of Revenue
Net Cash Flow	$-3.38M	$M	$M
PE Ratio

Splits
Feb 13, 2023	1:20
Dec 27, 2018	1:1000
Sep 13, 2011	1:500